DrugPatentWatch Database Preview

Details for Patent: 8,648,107

Which drugs does patent 8,648,107 protect, and when does it expire?

Patent 8,648,107 protects ACULAR LS and is included in one NDA.

This patent has four patent family members in three countries.

Summary for Patent: 8,648,107

Title:	Ketorolac tromethamine compositions for treating or preventing ocular pain
Abstract:	Compositions comprising ketorolac tromethamine at a therapeutically effective concentration of less than 0.5% are disclosed herein. Methods of treating or preventing ocular pain using said compositions are also disclosed herein.
Inventor(s):	Muller; Christopher A. (Foothill Ranch, CA), Cheetham; Janet K. (Laguna Niguel, CA), Kuan; Teresa H. (Placentia, CA), Power; David F. (Trabuco Canyon, CA)
Assignee:	Allergan Sales, LLC (Irvine, CA)
Application Number:	13/830,150
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 8,648,107

Glossary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Allergan	ACULAR LS	ketorolac tromethamine	SOLUTION/DROPS;OPHTHALMIC	021528-001	May 30, 2003	AT	RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted

Non-Orange Book US Patents Family Members for Patent 8,648,107

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Patent No.	Title	Estimated Patent Expiration
9,216,167	Ketorolac tromethamine compositions for treating or preventing ocular pain	➤ Sign Up
8,377,982	Ketorolac tromethamine compositions for treating or preventing ocular pain	➤ Sign Up
8,008,338	Ketorolac tromethamine compositions for treating or preventing ocular pain	➤ Sign Up
8,946,281	Ketorolac tromethamine compositions for treating or preventing ocular pain	➤ Sign Up
Patent No.	Title	Estimated Patent Expiration

International Family Members for US Patent 8,648,107

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	2468664	➤ Sign Up
Canada	2967362	➤ Sign Up
European Patent Office	3217937	➤ Sign Up
World Intellectual Property Organization (WIPO)	2016077726	➤ Sign Up
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Summary for Patent: 8,648,107

For more information try a trial or see the plans and pricing